Side-by-side financials for COCP and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COCP | NVS |
|---|---|---|
| Market cap | - | $282.64 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $2.01M | - |
| Net income (latest FY) | -$8.83M | - |
| Net margin | -438.5% | - |
| SEC filings | 655 | 947 |
Full pages: Cocrystal Pharma, Inc. and Novartis AG, or browse the full rankings.